Is ZIOP A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is a good investment right now.
Posts Tagged ‘NASDAQ:ZIOP’
ZIOPHARM Oncology (ZIOP) Has Fallen 47% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks.
ZIOPHARM Oncology Inc. (ZIOP): Are Hedge Funds Right About This Stock?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On ZIOPHARM Oncology Inc. (ZIOP)
Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Hedge Funds Have Never Been More Bullish On ZIOPHARM Oncology Inc. (ZIOP)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.
Do Hedge Funds Love ZIOPHARM Oncology Inc. (ZIOP)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Highlighting ZIOPHARM Oncology Inc. (ZIOP) As A Catalyst Play This Quarter
In Donald Trump’s latest press conference, the President-elect took a swipe at the healthcare and pharmaceutical space, suggesting that drug companies are getting away with ...
Should You Avoid ZIOPHARM Oncology Inc. (ZIOP)?
We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks.
5 Stocks Hedge Funds Hate The Most
Insider Monkey keeps a keen eye on the activity of the top hedge funds in the world, as our research has shown that hedge funds’ long positions can deliver market-beating returns...
High Volume Movers: Twitter, Sanchez Energy, Gold Fields, More
All three indexes are now in the red as some traders take profit from the market's run-up since the Brexit, while others remain cautious given the state of the global economy.
What’s the Deal With These Trending Stocks: Chipotle, Rite Aid, Alere, Tata Motors, ZIOPHARM Oncology
The markets have struggled to extend their record-making gains achieved earlier this week as investors react to Thursday’s terrorist attack in Nice, France.
Here’s Why Mobileye, Fitbit, & More are in the Red Today
With all three indexes in the green today, shares of Mobileye NV (NYSE:MBLY), Fitbit Inc (NYSE:FIT), Gladstone Capital Corporation (NASDAQ:GLAD), and ZIOPHARM Oncology Inc.
Hedge Funds Are Selling ZIOPHARM Oncology Inc. (ZIOP)
We can judge whether ZIOPHARM Oncology Inc.
Why Are These Bio-Tech Stocks Surging Today?
The U.S stock market seems to be heading for a second day of losses, as the morning rally has not lasted.
Three Biotech Stocks Are Down Today but Hedge Funds Say They Are Not Out
Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Intrexon Corp (NYSE:XON), and Heron Therapeutics Inc (NASDAQ:HRTX) are down significantly today amid a broader market decline.
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Should You Buy Pacific Biosciences of California (PACB)?
To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
In the eyes of many investors, hedge funds are viewed as overrated, old investment vehicles of an era lost to time.
Hedge Funds Are Buying ZIOPHARM Oncology Inc. (ZIOP)
In the eyes of most stock holders, hedge funds are seen as underperforming, outdated financial vehicles of years past.
Is Pacific Biosciences of California (PACB) Going to Burn These Hedge Funds?
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Geron Corporation (GERN): Are Hedge Funds Right About This Stock?
To most investors, hedge funds are assumed to be worthless, old investment tools of the past.
Threshold Pharmaceuticals, Inc. (THLD): A Biotech That Investors Need To Know About
Biotech stocks can provide astronomical returns but also depressing losses.
Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds' portfolio at the end of March.
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
BioDelivery Sciences International, Inc.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood.
Do Hedge Funds and Insiders Love ZIOPHARM Oncology Inc. (ZIOP)?
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) was in 6 hedge funds' portfolio at the end of December.
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident.
Biogen Idec Inc. (BIIB), United Therapeutics Corporation (UTHR), Repros Therapeutics Inc (RPRX): This Week in Biotech
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector...
Gilead Sciences, Inc. (GILD), Idenix Pharmaceuticals Inc (IDIX), ZIOPHARM Oncology Inc. (ZIOP), Vanguard Health Systems, Inc. (VHS): 3 Horrendous Health-Care Stocks This Week
Have you checked your 401(k) or IRA balance lately? If you're like many people, the numbers brought forth a smile, with the major indexes hitting record highs.
ZIOPHARM Oncology Inc. (ZIOP), Ariad Pharmaceuticals, Inc. (ARIA): 3 Reasons Investors Are Scared of Biotech Stocks
Biotechs offer the possibility of monster returns. Overnight doubles aren't out of the question.
3 Potential Game-Changing Cancer Drugs: Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK), ZIOPHARM Oncology Inc. (ZIOP)
Cancer just might be one of the scariest words in the English language. What goes through your mind when you hear that someone close to you has cancer? Sadness, probably.
This Week in Biotech: AbbVie Inc (ABBV) and More
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Humongous Health-Care Stocks This Week: Pharmacyclics, Inc. (PCYC) and More
Sweet! No, I'm not talking about leftover Valentine's Day candy and chocolates. Sweet is the operative word for the returns attained by several health-care stocks this week.
3 Biotechs Burning Through Cash: Keryx Biopharmaceuticals (KERX), Peregrine Pharmaceuticals (PPHM) and More
Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue.
